Search Results - "Marlatt, Michael W"

Refine Results
  1. 1

    Running throughout middle‐age improves memory function, hippocampal neurogenesis, and BDNF levels in female C57BL/6J mice by Marlatt, Michael W., Potter, Michelle C., Lucassen, Paul J., van Praag, Henriette

    Published in Developmental neurobiology (Hoboken, N.J.) (01-06-2012)
    “…Age‐related memory loss is considered to commence at middle‐age and coincides with reduced adult hippocampal neurogenesis and neurotrophin levels. Consistent…”
    Get full text
    Journal Article
  2. 2

    Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition by Lucassen, Paul, Hoozemans, Jeroen, van Haastert, Elise S., Aronica, Eleonora, Bauer, Jan, Marlatt, Michael W., Joels, Marian

    Published in Neural plasticity (01-01-2014)
    “…Microglia and astrocytes contribute to Alzheimer’s disease (AD) etiology and may mediate early neuroinflammatory responses. Despite their possible role in…”
    Get full text
    Journal Article
  3. 3

    Distinct structural plasticity in the hippocampus and amygdala of the middle-aged common marmoset ( Callithrix jacchus) by Marlatt, Michael W., Philippens, Ingrid, Manders, Erik, Czéh, Boldizsár, Joels, Marian, Krugers, Harm, Lucassen, Paul J.

    Published in Experimental neurology (01-08-2011)
    “…Adult neurogenesis in the primate brain is generally accepted to occur primarily in two specific areas; the subgranular zone (SGZ) of the hippocampal dentate…”
    Get full text
    Journal Article
  4. 4

    Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice by Marlatt, Michael W, Lucassen, Paul J, van Praag, Henriette

    Published in Brain research (23-06-2010)
    “…Abstract Hippocampal neurogenesis can be regulated by extrinsic factors, such as exercise and antidepressants. While there is evidence that the selective…”
    Get full text
    Journal Article
  5. 5

    Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease by Marlatt, Michael W, Potter, Michelle C, Bayer, Thomas A, van Praag, Henriette, Lucassen, Paul J

    Published in Current topics in behavioral neurosciences (01-01-2013)
    “…Reductions in adult neurogenesis have been documented in the original 3xTg mouse model of Alzheimer's disease (AD), notably occurring at the same age when…”
    Get more information
    Journal Article
  6. 6

    Presenilin mouse and zebrafish models for dementia: focus on neurogenesis by van Tijn, Paula, Kamphuis, Willem, Marlatt, Michael W, Hol, Elly M, Lucassen, Paul J

    Published in Progress in neurobiology (01-02-2011)
    “…Autosomal dominant mutations in the presenilin gene PSEN cause familial Alzheimer's disease (AD), a neurological disorder pathologically characterized by…”
    Get full text
    Journal Article
  7. 7

    Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies by Marlatt, Michael W, Lucassen, Paul J, Perry, George, Smith, Mark A, Zhu, Xiongwei

    Published in Journal of Alzheimer's disease (01-10-2008)
    “…Many lines of independent research have provided convergent evidence regarding oxidative stress, cerebrovascular disease, dementia, and Alzheimer's disease…”
    Get more information
    Journal Article
  8. 8

    Induction of Alzheimer's-like changes in brain of mice expressing mutant APP fed excess methionine by McCampbell, Alexander, Wessner, Keith, Marlatt, Michael W, Wolffe, Carrie, Toolan, Dawn, Podtelezhnikov, Alexei, Yeh, Suzie, Zhang, Rena, Szczerba, Peter, Tanis, Keith Q, Majercak, John, Ray, William J, Savage, Mary

    Published in Journal of neurochemistry (2011)
    “…J. Neurochem. (2011) 116, 82-92. ABSTRACT: Elevated plasma homocysteine, a risk factor for Alzheimer's disease, could result from increased production from…”
    Get full text
    Journal Article
  9. 9

    Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease by Clark, Timothy A, Lee, Hyun Pil, Rolston, Raj K, Zhu, Xiongwei, Marlatt, Michael W, Castellani, Rudy J, Nunomura, Akihiko, Casadesus, Gemma, Smith, Mark A, Lee, Hyoung-Gon, Perry, George

    “…Oxidative imbalance is one of the earliest manifestations of Alzheimer disease (AD) actually preceding the classic pathology of amyloid β deposits and…”
    Get full text
    Journal Article
  10. 10

    The cell cycle in Alzheimer disease: A unique target for neuropharmacology by Webber, Kate M., Raina, Arun K., Marlatt, Michael W., Zhu, Xiongwei, Prat, María I., Morelli, Laura, Casadesus, Gemma, Perry, George, Smith, Mark A.

    Published in Mechanisms of ageing and development (01-10-2005)
    “…Several hypotheses have been proposed attempting to explain the pathogenesis of Alzheimer disease including, among others, theories involving amyloid…”
    Get full text
    Journal Article
  11. 11

    Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis by WEBBER, KATE M., CASADESUS, GEMMA, MARLATT, MICHAEL W., PERRY, GEORGE, HAMLIN, CLIVE R., ATWOOD, CRAIG S., BOWEN, RICHARD L., SMITH, MARK A.

    Published in Annals of the New York Academy of Sciences (01-06-2005)
    “…: Epidemiological data showing a predisposition of women to develop Alzheimer disease (AD) led many researchers to investigate the role of sex steroids, namely…”
    Get full text
    Journal Article
  12. 12

    Therapeutic opportunities in Alzheimer disease: one for all or all for one? by Marlatt, Michael W, Webber, Kate M, Moreira, Paula I, Lee, Hyoung-gon, Casadesus, Gemma, Honda, Kazuhiro, Zhu, Xiongwei, Perry, George, Smith, Mark A

    Published in Current medicinal chemistry (01-01-2005)
    “…In recent years, Alzheimer disease (AD) has received great attention as an incurable and fatal disease that threatens the lives of aging individuals. Debates…”
    Get more information
    Journal Article
  13. 13

    The Application of Microarray Technology to Neuropathology: Cutting Edge Tool With Clinical Diagnostics Potential or Too Much Information? by McShea, Andrew, Marlatt, Michael W, Lee, Hyoung-gon, Tarkowsky, Stephanie M, Smit, Mariya, Smith, Mark A

    “…Microarray technology is a tremendously powerful method for simultaneously monitoring the expression of thousands of species of nucleic acids, usually cellular…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ 25–35 by Kaminsky, Yury G., Marlatt, Michael W., Smith, Mark A., Kosenko, Elena A.

    Published in Experimental neurology (2010)
    “…Amyloid-β peptide (Aβ) is a central player in the pathogenesis and diagnosis of Alzheimer disease. It aggregates to form the core of Alzheimer…”
    Get full text
    Journal Article
  17. 17

    Subcellular and metabolic examination of amyloid- beta peptides in Alzheimer disease pathogenesis: Evidence for A beta sub(25-35) by Kaminsky, Yury G, Marlatt, Michael W, Smith, Mark A, Kosenko, Elena A

    Published in Experimental neurology (01-01-2010)
    “…Amyloid- beta peptide (A beta ) is a central player in the pathogenesis and diagnosis of Alzheimer disease. It aggregates to form the core of Alzheimer…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35) by Kaminsky, Yury G, Marlatt, Michael W, Smith, Mark A, Kosenko, Elena A

    Published in Experimental neurology (01-01-2010)
    “…Amyloid-beta peptide (Abeta) is a central player in the pathogenesis and diagnosis of Alzheimer disease. It aggregates to form the core of Alzheimer…”
    Get full text
    Journal Article